Top compounds associated with response to BPIFC


Feature Type Standardized
Nominal ANOVA
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.077 0.01
mRNA SB-525334 CTRPv2 pan-cancer AAC 0.089 0.01
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.083 0.02
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.083 0.02
mRNA paclitaxel gCSI pan-cancer AAC -0.12 0.02
mRNA prima-1 CTRPv2 pan-cancer AAC 0.07 0.02
mRNA tivozanib GDSC1000 pan-cancer AAC 0.077 0.02
mRNA MLN2238 CTRPv2 pan-cancer AAC 0.075 0.03
mRNA ABT-263 CTRPv2 pan-cancer AAC 0.077 0.03
mRNA 17-AAG CCLE pan-cancer AAC -0.1 0.03
Download CSV